Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 65 results for "novartis india"

India Needs Predictable Intellectual Property Rights Regime: Novartis

India Needs Predictable Intellectual Property Rights Regime: N...

New Delhi: A "highly predictable" IPR regime is needed for the pharma industry in India to develop to the level of the US or Europe, a senior executive of Swiss drug major Novartis said on Tuesday. "If India wants to develop to the same framework ... NDTV, 1 week ago
India needs predictable IPR regime: Novartis Press Trust of India, 1 week ago

Taken remedial actions at two plants in Maharashtra: Drug firm Novartis

NEW DELHI: Drug firm Novartis today said it has taken remedial action at its two plants in Western India which had received a warning letter from the US health regulator and expects the manufacturing facility to returm to normal functioning soon. ...
 Economic Times1 week ago Taken remedial actions at 2 plants in Maha: Novartis  Press Trust of India1 week ago Top Novartis exec in India says two plants warned by FDA completing remediation  FiercePharmaManufacturing1 week ago

Top 50 pharma cos report negative growth in profit in first half of 2015-16

The outlook for the Indian pharmaceutical sector for the year ending March 2016 will be extremely bleak if the half yearly performance of top companies is any indication. Based on the financial performance of leading 50 Indian pharmaceutical ...
 PharmaBiz1 week ago
NDTV Profit

Delhi HC tells govt not to take coercive steps against pharma cos

Petitions were filed by pharma companies and an association of medicine manufacturing firms challenging the government's new drug pricing order that asked them to slash prices of 348 medicines The Delhi High Court has told the government not to ...
 Financial Express5 days ago Don't coerce pharma cos that flout pricing rules: HC to Govt  Millennium Post5 days ago Drug pricing: Don't take coercive steps against pharma cos: HC  Press Trust of India5 days ago

Liquidator kept out of SFCs claims

The Supreme Court last week ruled that the official liquidator of a wound-up company cannot exercise any power to adjudicate and determine the claims of statutory corporations when the company judge has permitted them to stand outside the ...
 Business Standard India5 days ago

More Pfizer-Allergan-like deals in the offing

Mumbai, Nov 23: Drug giant Pfizer is not new to tectonic acquisitions. But if there's one clear message from its $160 billion overture to buy Botox-maker Allergan, it is that drug companies are trying every trick in the book to keep their head ...
 Hindu Business Line6 days ago Pfizer-Allergan deal: The day of the mega transaction is not over  Hindu Business Line6 days ago
Financial Express

11 stocks in focus today: Infosys, Dishman Pharma, Essar Ports and more

The benchmark BSE Sensex fell by over 68 points in opening trade on Wddnesday following profit-booking by investors after recent gains despite a firm trend in other Asian markets. At 9.54 am, Sensex was trading 10.08 points down at 25,854.39.
 Financial Express1 week ago

Swiss envoy: Maggi ban sent negative message to investors

12:27 am New Delhi : At a time when the Modi Sarkar is going all out to woo foreign investors and improving the country's global standing on the parameters for ease of business, Swiss Ambassador Linus von Castelmur has said that the ban on Maggi ...
 The Freepress Journal1 week ago

Greece seals deal to unlock 12 bn euros bailout funds

12:25 am Athens : Greece announced that it has struck a deal with its international creditors to unblock some 12 billion euros in much-needed bailout loans. We have reached agreement on everything, including the 48 additional measures that should ...
 The Freepress Journal1 week ago
Business Today India

Novartis' net profit buoyed due to sale of OTC division

MUMBAI: Novartis India reported a total income of Rs 448 crore from operations for the half-year ended September 2015. Its net profit increased to Rs 103.82 crore for the September quarter on back of slump sale of its OTC division to GlaxoSmithKline ...
 Times of India3 weeks ago Novartis India net jumps to Rs.104 cr in Q2  PharmaBiz3 weeks ago Novartis surges 6% after multi-fold jump in Q2 profit  Business Today India3 weeks ago Novartis India net rises to Rs 104 cr on slump sale of OTC biz  Hindu Business Line3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less